Gonorrhea Diagnostic Market Analysis By Marketing Channel Development Trend And Industry Effect Factors Analysis By 2027
Gonorrhea Diagnostic Market report studies the Gonorrhea Diagnostic with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Gonorrhea Diagnostic Market analysis segmented by companies, region, type and applications in the report.
Scope of Gonorrhea Diagnostic: Gonorrhea Diagnostic Market report evaluates the growth rate and the market value based on market dynamics, growth inducing factors. Complete knowledge is based on the latest industry news, opportunities, and trends. The report contains a comprehensive market analysis and vendor landscape in addition to a SWOT analysis of the key vendors.
Gonorrhea is a sexually transmitted disease caused by a bacterium Neisseria Gonorrhoeae. It is one of the most common sexually transmitted diseases and affects millions of people each year. According to the study, ‘Global epidemiology of Neisseria gonorrhoeae in infertile populations: systematic review, meta-analysis and metaregression’, published in BMJ Journals in May 2020, the pooled mean prevalence of current gonorrhoea infection worldwide was at 2.2%, with the highest prevalence in Africa at 5.0%. Thus, high prevalence of gonorrhea in emerging economies is expected to propel growth of the gonorrhea diagnostic market.
Diagnostic tools available in the gonorrhea diagnostic market include urine test, swab test and nucleic acid amplification testing (NAAT). The gonorrhea diagnostic market is witnessing R&D of new approaches for diagnosis. In May 2021, researchers from Johns Hopkins University reported development of PROMPT (portable, rapid, on-cartridge, magnetofluidic purification and testing platform), an inexpensive portable device and a complimenting smartphone app that can diagnose gonorrhea infection in under 15 minutes. The study was published in Science Translational Medicine.
Emergence of Covid-19 has led to significant rise in sexually transmitted diseases, which is also expected to aid in growth of the gonorrhea diagnostic market. In November 2020, a study conducted in two main STI centers in Milan, Italy, revealed that diagnosis of STIs, including gonorrhea, secondary syphilis and mycoplasma genitalium (MG) has increased despite the lockdown restrictions. The study results were presented at the 29th European Academy of Dermatology and Venereology virtual conference.
Players in the gonorrhea diagnostic market are focused on expanding their distribution channel. In February 2021, Binx Health, a provider of point-of-care diagnostic solutions, partnered with McKesson, a healthcare company, for the sale and distribution of the Binx io molecular diagnostic testing platform in the US. The point-of-care platform enables the diagnosis and subsequent treatment of chlamydia and gonorrhea to take place in a single visit. Later, in April 2021, the Food and Drug Administration granted a CLIA waiver for the binx health io CT/NG assay, thereby allowing the use of the binx health io CT/NG assay at point-of-care settings.
The gonorrhea diagnostic market in North America is expected to witness significant growth with surge in cases of gonorrhea infections. According to a Michigan Department of Health and Human Services press release, in Michigan reported a 22% increase in reported gonorrhea infections for 2020 compared to 18,264 gonorrhea infections in 2019.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/126
Gonorrhea Diagnostic Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Becton, Dickinson and Company, Baxter International, Inc., Pfizer Inc., B. Braun Melsungen AG, Fresenius SE & CO. KGaA, Medtronic plc, Smiths Group plc, Terumo Corporation, Moog, Inc., F. Hoffmann-la Roche Ltd., and Johnson & Johnson.
Main points in Gonorrhea Diagnostic Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Gonorrhea Diagnostic Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Gonorrhea Diagnostic Industry Impact
Chapter 2 Global Gonorrhea Diagnostic Competition by Types, Applications, and Top Regions and Countries
2.1 Global Gonorrhea Diagnostic (Volume and Value) by Type
2.3 Global Gonorrhea Diagnostic (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Gonorrhea Diagnostic Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Gonorrhea Diagnostic Market Analysis
Chapter 6 East Asia Gonorrhea Diagnostic Market Analysis
Chapter 7 Europe Gonorrhea Diagnostic Market Analysis
Chapter 8 South Asia Gonorrhea Diagnostic Market Analysis
Chapter 9 Southeast Asia Gonorrhea Diagnostic Market Analysis
Chapter 10 Middle East Gonorrhea Diagnostic Market Analysis
Chapter 11 Africa Gonorrhea Diagnostic Market Analysis
Chapter 12 Oceania Gonorrhea Diagnostic Market Analysis
Chapter 13 South America Gonorrhea Diagnostic Market Analysis
Chapter 14 Company Profiles and Key Figures in Gonorrhea Diagnostic Business
Chapter 15 Global Gonorrhea Diagnostic Market Forecast (2021-2027)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
- CDN Newswire